Capital Impact Advisors, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 137 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$136,000
-4.2%
23,4130.0%0.06%
-5.9%
Q1 2016$142,000
-33.6%
23,4130.0%0.07%
-33.3%
Q4 2015$214,000
+62.1%
23,4130.0%0.10%
+52.2%
Q3 2015$132,000
-49.2%
23,4130.0%0.07%
-43.2%
Q2 2015$260,000
-29.2%
23,4130.0%0.12%
-29.8%
Q1 2015$367,00023,4130.17%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders